Astria Therapeutics Inc Newsroom

LifeSci Capital Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $23

Futu NewsDec 12 04:31

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Futu NewsDec 12 01:31

Oppenheimer Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Raises Target Price to $32

Futu NewsDec 12 01:31

Astria Therapeutics Analyst Ratings

BenzingaDec 11 01:16

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Futu NewsDec 10 23:31

TD Cowen Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $35

Futu NewsNov 20 20:33

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $23 to $35

Futu NewsNov 15 21:03

Astria Therapeutics Is Maintained at Outperform by Oppenheimer

Dow JonesNov 14 21:28

Astria Therapeutics Analyst Ratings

BenzingaNov 14 21:19

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Futu NewsNov 14 19:31

LifeSci Capital Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $25

Futu NewsOct 25 03:31

Astria Therapeutics Analyst Ratings

BenzingaSep 27 18:42

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Futu NewsSep 27 18:33

Evercore Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $25

Futu NewsSep 26 20:31

TD Cowen Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $35

Futu NewsSep 26 06:31

Evercore Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Raises Target Price to $25

Futu NewsAug 15 14:32

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $16 to $35

Futu NewsAug 14 21:00

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $16 to $35

Futu NewsAug 13 21:00

Astria Therapeutics Price Target Maintained With a $22.00/Share by Wedbush

Dow JonesAug 13 20:47

Astria Therapeutics Analyst Ratings

BenzingaAug 13 19:12